Advanced in Temporal Arteritis

Michihiro Ogasawara

Tokyo, JP 
Advanced in Temporal Arteritis
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Michihiro Ogasawara practices in Tokyo, Japan. Ogasawara is rated as an Advanced expert by MediFind in the treatment of Temporal Arteritis. Their top areas of expertise are Rheumatoid Arthritis (RA), Giant Cell Arteritis (GCA), Temporal Arteritis, and Synovitis.

Their clinical research consists of co-authoring 42 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Temporal Arteritis.

Locations

Tokyo, Japan
Other Locations
Nagoya, 4668560, Japan
Hongo, 1138421, Japan
Tokorozawa, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

42 Total Publications

Inflammatory Findings on Musculoskeletal Ultrasound Do Not Affect Pain Intensity but May Influence Pain Quality in Patients with Refractory Arthralgia: A Cross-Sectional Study Using PainDETECT and Musculoskeletal Ultrasound.
Inflammatory Findings on Musculoskeletal Ultrasound Do Not Affect Pain Intensity but May Influence Pain Quality in Patients with Refractory Arthralgia: A Cross-Sectional Study Using PainDETECT and Musculoskeletal Ultrasound.
Journal: Cureus
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ogasawara's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile